R N Barker
Overview
Explore the profile of R N Barker including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
766
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jackson S, Solomon S, Barker R
Disabil Rehabil
. 2021 Feb;
44(15):3843-3852.
PMID: 33625948
Purpose: Recovering from stroke in remote Australia has rarely been considered, even though rehabilitation services are generally scarce. The primary purpose of this study was to explore stroke recovery, from...
2.
Kotb I, Lewis B, Barker R, Ormerod A
Br J Dermatol
. 2018 Jan;
179(1):127-135.
PMID: 29330859
Background: Psoriasis is a chronic T-cell-mediated skin disease with marked social and economic burdens. Current treatments are unsatisfactory, with unpredictable remission times and incompletely understood modes of action. Recent advances...
3.
Carr J, Kendall M, Amsters D, Pershouse K, Kuipers P, Buettner P, et al.
Spinal Cord
. 2016 Nov;
55(2):192-197.
PMID: 27897188
Study Design: Sequential mixed method design. Objectives: Determine factors associated with community participation for individuals with spinal cord injury (SCI). Setting: Queensland, Australia. Methods: Phase I consisted of a quantitative...
4.
Chakravarty P, Porter C, Cao H, Cairns L, Moss M, Duthie R, et al.
Transfus Med
. 2016 Mar;
26(2):147-9.
PMID: 27000682
No abstract available.
5.
Pickford W, Gudi V, Haggart A, Lewis B, Herriot R, Barker R, et al.
Clin Exp Immunol
. 2014 Dec;
180(2):189-200.
PMID: 25472480
Bullous pemphigoid is a blistering skin disease characterized by autoantibodies against the NC16a domain of bullous pemphigoid 180. This study was performed to characterize and map the fine specificity of...
6.
Forrester M, Robertson L, Bayoumi N, Keavney B, Barker R, Vickers M
Clin Exp Immunol
. 2014 Jul;
178(2):373-83.
PMID: 24975574
Although it is widely believed that interleukin (IL)-27 is anti-inflammatory, its role in controlling human immune responses is not fully established. In particular, its interactions with T helper type 17...
7.
Dahal L, Hall L, Barker R, Ward F
Clin Exp Immunol
. 2013 Apr;
173(1):58-66.
PMID: 23607691
Autoimmune haemolytic anaemia (AIHA) is caused by autoantibodies against red blood cell (RBC) surface antigens that render RBC susceptible to Fc-mediated phagocytosis and complement-mediated lysis. Experimental AIHA can be induced...
8.
Lewis B, Rajpara S, Haggart A, Wilson H, Barker R, Ormerod A
Clin Exp Immunol
. 2013 Apr;
173(1):38-46.
PMID: 23607572
Recent evidence points to the T helper type 17 (Th17) subset as key in the pathogenesis of psoriasis, but cells of this type in lesions remain to be fully characterized....
9.
McKenzie C, Koser U, Lewis L, Bain J, Mora-Montes H, Barker R, et al.
Infect Immun
. 2010 Feb;
78(4):1650-8.
PMID: 20123707
The pathogenicity of the opportunistic human fungal pathogen Candida albicans depends on its ability to escape destruction by the host immune system. Using mutant strains that are defective in cell...
10.
Barker R, Kendall M, Amsters D, Pershouse K, Haines T, Kuipers P
Spinal Cord
. 2008 Jul;
47(2):149-55.
PMID: 18594553
Study Design: Prospective cross-sectional survey. Objectives: To compare quality of life (QOL) for people with spinal cord injury (SCI) and their able-bodied peers and to investigate the relationship between QOL...